欧康医药
(920230)
| 流通市值：5.58亿 | | | 总市值：11.89亿 |
| 流通股本：4724.78万 | | | 总股本：1.01亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 9,099,349.82 | 6,024,252.63 | 9,899,134.83 | 29,564,912.17 |
| 交易性金融资产 | 51,682,275.57 | 32,558,837.4 | 35,080,494.23 | 37,847,345.5 |
| 应收票据及应收账款 | 72,786,100.93 | 104,826,078.94 | 60,218,120.53 | 53,287,565.6 |
| 其中：应收票据 | 368,431.87 | 1,203,618.63 | 310,070 | 2,789,350.11 |
| 应收账款 | 72,417,669.06 | 103,622,460.31 | 59,908,050.53 | 50,498,215.49 |
| 应收款项融资 | 594,544.05 | 248,321.05 | 1,545,913.13 | 254,460 |
| 预付款项 | 11,862,641.26 | 8,176,755.84 | 21,695,975.09 | 15,805,139.6 |
| 其他应收款合计 | 936,398.27 | 573,189.36 | 1,844,037.88 | 1,142,630.43 |
| 存货 | 102,912,029.16 | 102,496,942.26 | 101,737,825.58 | 92,585,620.76 |
| 其他流动资产 | 3,821,171.44 | 6,975,984.64 | 4,032,720.31 | 4,890,312.42 |
| 流动资产合计 | 253,694,510.5 | 261,880,362.12 | 236,054,221.58 | 235,377,986.48 |
| 非流动资产: | | | | |
| 固定资产 | 242,855,213.37 | 246,683,172.09 | 220,728,012.45 | 226,062,057.1 |
| 在建工程 | 6,629,351.64 | 6,459,756.67 | 29,189,678.75 | 21,667,097.4 |
| 使用权资产 | 756,261.24 | 840,104.11 | 552,287.91 | 657,654.06 |
| 无形资产 | 10,939,713.94 | 11,115,168.64 | 10,805,764.98 | 11,194,512.84 |
| 长期待摊费用 | 101,446.54 | - | - | - |
| 递延所得税资产 | 2,531,095.93 | 2,601,547.18 | 2,474,507.58 | 2,532,680.73 |
| 其他非流动资产 | 2,205,452.16 | 2,003,186.14 | 4,819,796.96 | 5,054,863.14 |
| 非流动资产合计 | 266,018,534.82 | 269,702,934.83 | 268,570,048.63 | 267,168,865.27 |
| 资产总计 | 519,713,045.32 | 531,583,296.95 | 504,624,270.21 | 502,546,851.75 |
| 流动负债: | | | | |
| 短期借款 | 22,017,208.33 | 21,023,875 | 21,015,888.5 | 21,009,459.4 |
| 应付票据及应付账款 | 42,536,554.63 | 56,681,601.19 | 40,827,590.15 | 41,412,156.14 |
| 其中：应付票据 | 1,488,721.97 | 3,906,402.75 | 3,715,630.87 | 1,297,950.09 |
| 应付账款 | 41,047,832.66 | 52,775,198.44 | 37,111,959.28 | 40,114,206.05 |
| 合同负债 | 644,902.34 | 683,005.17 | 2,412,990.72 | 1,047,833.33 |
| 应付职工薪酬 | 2,280,522.13 | 3,761,007.6 | 2,335,201.96 | 2,127,092.05 |
| 应交税费 | 169,616.07 | 173,821.3 | 80,512.9 | 61,482.81 |
| 其他应付款合计 | 16,325,019.75 | 16,559,073.42 | 16,692,943.21 | 18,043,016.64 |
| 一年内到期的非流动负债 | 351,949.76 | 377,591.68 | 251,709.99 | 247,951.07 |
| 其他流动负债 | 83,837.3 | 390,224.54 | 313,688.8 | 271,439.62 |
| 流动负债合计 | 84,409,610.31 | 99,650,199.9 | 83,930,526.23 | 84,220,431.06 |
| 非流动负债: | | | | |
| 租赁负债 | 444,427.73 | 486,202.16 | 300,235.97 | 368,926.85 |
| 递延收益 | 12,633,989.62 | 12,983,384.56 | 13,360,280.21 | 13,713,675.14 |
| 非流动负债合计 | 13,078,417.35 | 13,469,586.72 | 13,660,516.18 | 14,082,601.99 |
| 负债合计 | 97,488,027.66 | 113,119,786.62 | 97,591,042.41 | 98,303,033.05 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 100,717,495 | 100,717,495 | 100,717,495 | 100,447,495 |
| 资本公积 | 196,390,468.6 | 195,631,165.3 | 195,135,534.78 | 193,371,130.98 |
| 减:库存股 | 7,296,753.3 | 7,296,753.3 | 9,951,819 | 8,850,219 |
| 其他综合收益 | -129,607.5 | -81,529.9 | -68,764.04 | -52,089.59 |
| 专项储备 | 7,967,546.4 | 7,096,901.72 | 6,361,407.01 | 5,491,345.67 |
| 盈余公积 | 19,894,471.41 | 19,894,471.41 | 18,639,990.8 | 18,639,990.8 |
| 未分配利润 | 104,230,587.83 | 102,025,914.75 | 95,892,753.45 | 94,867,847.07 |
| 归属于母公司股东权益合计 | 421,774,208.44 | 417,987,664.98 | 406,726,598 | 403,915,500.93 |
| 少数股东权益 | 450,809.22 | 475,845.35 | 306,629.8 | 328,317.77 |
| 股东权益合计 | 422,225,017.66 | 418,463,510.33 | 407,033,227.8 | 404,243,818.7 |
| 负债和股东权益合计 | 519,713,045.32 | 531,583,296.95 | 504,624,270.21 | 502,546,851.75 |
| 公告日期 | 2026-04-29 | 2026-04-15 | 2025-10-30 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |